The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide

H. Buter, M.H. Hemmelder, Ger Jan Navis, P.E. De Jong, Dick de Zeeuw

Research output: Contribution to journalArticleAcademicpeer-review

188 Citations (Scopus)

Abstract

Background. Dietary sodium restriction enhances the antiproteinuric and blood pressure lowering effect of ACE inhibition. In clinical practice, however, long-term compliance to a low-sodium diet may be difficult to obtain. We therefore investigated whether the blunting of the antiproteinuric and blood pressure lowering efficacy of ACE inhibition by high sodium intake can be restored by the addition of a diuretic.

Patients and methods. Seven proteinuric patients with non-diabetic renal disease on chronic ACE inhibition were studied during three consecutive 4-week periods: low sodium (50 mmol/day), high sodium (200 mmol/day) and high sodium plus hydrochlorothiazide (50 mg o.i.d.).

Results. During low sodium intake proteinuria was 3.1 (0.7-5.2) g/day, during high sodium intake proteinuria increased to 4.5 (1.6-9.2)g/day (P

Conclusion. Addition of hydrochlorothiazide can overcome the blunting of the therapeutic efficacy of ACE inhibition on proteinuria and blood pressure by a high sodium intake.

Original languageEnglish
Pages (from-to)1682 - 1685
Number of pages4
JournalNephrology Dialysis Transplantation
Volume13
Issue number7
Publication statusPublished - Jul-1998

Keywords

  • ACE inhibition
  • hydrochlorothiazide
  • nondiabetic renal disease
  • proteinuria
  • sodium restriction
  • CONVERTING ENZYME-INHIBITION
  • RENAL-DISEASE
  • PROGRESSION
  • PROTEINURIA
  • REDUCTION

Fingerprint

Dive into the research topics of 'The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide'. Together they form a unique fingerprint.

Cite this